Merck-Rosetta Inpharmatics, Salk Institute for Biological Studies, San Diego City Council, PacificGMP, University of California-Irvine Sue and Bill Gross Hall, Gilead Sciences, National Biodefense Analysis and Countermeasures Center, Alexandria Real Estat | GenomeWeb
Merck to Shutter Rosetta Research Center in Seattle, Two Overseas Sites
 
Merck disclosed plans last week to shut down three basic research sites worldwide by the end of 2009 — labs in Seattle; Pomezia, Italy; and Tsukuba, Japan — as part of a consolidation of research operations into four locations.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.